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Introduction
Tricho-hepato-enteric syndrome (SD/THE) is a rare autosomal recessive disorder that is classically associated with facial dysmorphism (wide forehead, hypertelorism, broad nasal root); abnormal hair (described as wooly, breakable, brittle, unbrushable and associated with trichorrhexis nodosa); chronic diarrhea and immune deficiency (mostly humoral deficiency) (Hartley et al., 2010; Fabre et al., 2011) . Moreover, about half of the patients were prematurely born, present hepatic disease including cirrhosis, siderosis, hepatomegaly and have skin abnormalities like café au lait spots or xerosis (Monies et al., 2015; Fabre et al., 2013a) . This syndrome is caused by mutations in the TTC37 or SKIVL2 genes, which encode for sub-units of the Ski complex, a cofactor of the cytoplasmatic exosomal RNA degradation pathway (Fabre et al., 2012 (Fabre et al., , 2013b . Over the last few years, milder phenotypes have been described and even patients with isolated immune defects have been reported (Oz-Levi et al., 2015; Rider et al., 2015) .
Multiple intestinal atresia with combined immune deficiency (MIA-CID) is another rare autosomal recessive disorder. It is classically associated with intestinal atresias that can occur throughout the gastrointestinal tract, particularly involving the small bowel. Short bowel syndrome due to intestinal resection and requirement of total parenteral nutrition are common features of this syndrome (Notarangelo, 2014; Chen et al., 2013) . Associated combined immunodeficiency is also commonly present, allegedly caused by deficient thymopoiesis and lymphocyte differentiation, proliferation, and survival. Therefore, recurrent and opportunistic infections are also present (Notarangelo, 2014; Lemoine et al., 2014) . This disease is caused by mutations in the TTC7A gene, involved in the regulation of the RhoA signaling pathway, crucial to normal ROCK function (allowing adequate cytoskeleton organization and epithelial cell polarity) (Notarangelo, 2014; Samuels et al., 2013; Fernandez et al., 2014) . Recently, some patients with MIA-CID having only mild intestinal defects and even patients without structural defects presenting only with very-early-onset inflammatory bowel disease (VEO-IBD) have been reported (Woutsas et al., 2015; Avitzur et al., 2014) .
We present the clinical report of a patient with overlapping features of both syndromes that was initially diagnosed as SD/THE. Whole 
Clinical report
A caucasian female infant was born at 33 weeks of gestation to unrelated parents. Her weight (2015 g), height (41 cm) and head circumference (30 cm) were on the 50th percentile. In the first weeks of her life, she presented feeding intolerance and at the age of two months, a type 1 ileal atresia was diagnosed. An ileostomy was performed and she was kept on both parenteral and enteral nutrition. At the age of 5 months she developed bloody diarrhea despite the presence of an ileostomy. The colonic histology revealed inflammatory pseudo-polyps, caliciform cells depletion, glandular distortion/atrophy, leading to the diagnosis of VEO-IBD. Her physical examination was notable for the presence of a prominent forehead, hypertelorism and enamel dysplasia ( Table 1 ). Her colitis worsened after the re-establishment of the continuity of the intestinal tract. At the age of 20 months she started to present self-limited but recurrent elevation of AST and ALT. The hepatic biopsy revealed the presence of mild fibrosis and interface hepatitis. There were no autoantibodies related to autoimmune hepatitis present in the serum.
She also presented unexplained episodes of leukocytosis (70-80% neutrophils) and thrombocytosis, not related to infections. The immunological evaluation showed normal lymphocyte subpopulations but severe and symptomatic hypogammaglobulinemia (recurrent respiratory infections), as well as absent serological response to vaccines. She also presented autoimmune thyroiditis.
She started subcutaneous immunoglobulin replacement at the age of 2 leading to a dramatic decrease of the number of infections. Moreover, the episodes of intermittent leukocytosis disappeared and she presented an improvement of the colonic inflammation, allowing adequate enteral nutrition.
Nevertheless, from the age of 3 to the age of 5, she has presented 3 episodes of simultaneous elevation of AST/ALT and bloody diarrhea, which responded to low-dose prednisolone (1 mg/kg/day) and azathioprine. At the moment, at the age of 5 years-old, she has been asymptomatic for the last 12 months. She is growing on the 50 th percentile of weight, height and head circumference. Her neurodevelopment is perfectly normal. The association of enteropathy, facial dysmorphy, dental abnormalities (enamel dysplasia), hepatic abnormalities and mild immunological involvement (isolated hypogammaglobulinemia) was evocative of SD/THE, despite the absence of hair abnormalities and the presence of a type 1 intestinal atresia (that had never been reported in SD/THE). In fact, type 1 atresia is not related to an interruption of the continuity of the intestinal tract, but is instead the presence of a membrane in the inner intestine.
However the direct sequencing of the TTC37 and SKIV2L genes revealed no mutation. A whole exome analysis was performed and showed a compound heterozygosity of TTC7A, with two missense 
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European Journal of Medical Genetics 61 (2018) 185-188 mutations in exon 14 and 21, which were confirmed in Sanger sequencing. In fact, the patient had VEO-IBD and an intestinal atresia, which were both previously linked to TTC7A deficiency. To our knowledge, this is the first report of a patient with TTC7A deficiency who presents simultaneously an intestinal atresia and VEO-IBD and also has hepatic involvement and the phenotypic features previously described.
Matherial and methods
Written consent for genetic and exome analysis were obtained from the patient and her parents. The Biobank of the Department of Genetics of La Timone Hospital proceeded with the DNA extraction and ensured the long-term storage of samples. Exome sequencing was performed after exome enrichment using Agilent XT Capture Exome V5 in Illumina HiSeq (2000)/2500 platform (Aros Applied Biotechnology A/S, Denmark). The variants were first filtered with the in-house "VarAFT" system (http://varaft.eu) focusing on the 29 genes linked to congenital diarrheal syndrome to date (Table 1 SI. (Canani et al., 2015; Posovszky, 2016) .
Using frequency below 0.01 on Exac Browser (http://exac. broadinstitute.org/) only one candidate gene remained: TTC7A. The patient has compound heterozygous mutations in the TTC7A gene (NG_034143.1):
• NM_001288951.1: c.2587G > A; p (Ala863Thr), inherited from the mother • NM_001288951.1:c.1616C > T; p (Ser539Leu). Inherited from the father Both were rare with respectively three and two alleles in Gnomad for c.2587G > A and c.1616C > T, with no description of homozygosity. Both variants were predicted to be pathogenic using bioinformatics tools (Polyphen: probably damaging; SIFT: deleterious; Mutation Taster: disease causing; UMD predictor: pathogenic). The variants were deposed in clinvar (SUB3050809). The TTC7A variants were confirmed by Sanger sequencing on a 3500XL Genetic Analyzer ® (ThermoFisher, Carlsbad, CA) and parental DNA samples were tested to confirm inheritance. (Fig. 1) . A second analysis without gene filtering did not find any other relevant candidate gene.
Discussion
We present the case of a patient with clinical features evocative of SD/THE but presenting missense mutations (probably hypomorphic) in TTC7A. We considered SD/THE to be the most probable diagnosis due to the presence of VEO-IBD, large forehead and the absence of combined immunodeficiency, despite the presence of a type 1 ileal atresia.
Indeed, there is significant clinical overlap of both syndromes (Table 2 ). This patient presents some features that had never been described before in patients with TTC7A mutations: hepatic involvement, dental anomalies, facial dysmorphism and mild immunological involvement). Additionally, even the coexistence of intestinal atresia and VEO-IBD in the same patient with TTC7A deficiency had never been described.
MIA-CID linked to TTC7A deficiency was only characterized in 2013 and in the following years a more precise characterization of the syndrome has been described. To date, there are 52 patients described worldwide and the syndrome seems to have two different phenotypes:
-Severe type, with multiple intestinal atresia and combined immunodeficiency, leading to premature death. -Mild type, with predominant features of VEO-IBD, less severe immunological involvement (some with auto-immune features), and hair abnormalities.
Interestingly enough, in a very recent past, some patients with TTC7A deficiency were described to present some dermatological features, namely ichthyosis. This characteristic was expected to be present, since the animal model KO to TTC7A presents severe dermatological features (Leclerc-Mercier et al., 2016) .
There seems to be some genotype/phenotype correlation with less severe phenotype linked to missense (probably hypomorphic) mutations, whereas the most severe phenotype is related to null mutations.
We believe that, despite the overlap that these two different conditions may present, the presence of intestinal atresia seems to be linked with TTC7A mutations, whereas woolly hair and trichorhexis nodosa (0,7-4,1) Anti-TPO Antibodies (UI/mL) 9,9 < 5,5 European Journal of Medical Genetics 61 (2018) 185-188 are tipically linked to SD/THE. However, there are less than 60 patients with both diseases reported. Thus, a clearer vision of these syndromes will most certainly arise as more patients are described. Finally, this case illustrates once again the importance of broad gene analysis (either targeted on a gene panel or whole exome sequencing) for the clarification of rare diseases with overlapping phenotypes.
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